top of page

Caught Too Late: Closing the Cancer Screening Gap

Updated: Sep 30


Cancer screening has a simple job: find disease before it becomes dangerous. But that only works if screening actually reaches everyone equally — and right now, it doesn't. Screening gaps are one of the single strongest drivers of late-stage cancer diagnosis, and they fall disproportionately on Indigenous, Black, rural, and low-income populations.


Where the Gaps Show Up

Lower mammography rates. Lower colonoscopy and FIT test participation. Lower lung cancer screening eligibility and uptake, even among those who qualify. Lower cervical cancer screening. Delayed follow-up after an abnormal result — sometimes the most dangerous gap of all, since the screening happened but the response didn't.


Why the Gaps Exist

Transportation barriers standing between patients and appointments. Justified mistrust of healthcare systems. A lack of culturally safe care. Insurance and cost barriers. Limited primary care access — often the entry point that triggers a screening referral in the first place. Provider bias. Health literacy gaps. Geographic isolation.


Where It Matters Most

Breast cancer screening lags in Black and Indigenous communities. Colorectal cancer screening shows stark rural and low-income disparities. Lung cancer screening has low uptake even among eligible high-risk patients who qualify but never get scanned. Cervical cancer screening rates drop in marginalized communities specifically.


What's Proven to Work

Mobile screening units that remove the transportation barrier entirely. Community-led screening programs built on existing trust. Culturally tailored outreach. Real navigation support, not just a pamphlet. Reminder systems. Telehealth pre-screening visits. Plain-language education that explains not just what a screening test is, but why it matters.


How AskEddy Helps

AskEddy helps patients understand screening guidelines that apply to them, prepare for appointments with the right questions, interpret results without panic or confusion, and follow up on abnormal findings — because the screening itself is only half the job.


Reviewed by Dr. Derrick J. Beech, MD, FACS, Surgical Oncologist


Sources: CDC — Cancer Health Equity; U.S. Preventive Services Task Force — Cancer Screening Recommendations


 
 
 

Comments


bottom of page